These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21465559)

  • 1. Understanding the binding mode and function of BMS-488043 against HIV-1 viral entry.
    Da LT; Quan JM; Wu YD
    Proteins; 2011 Jun; 79(6):1810-9. PubMed ID: 21465559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding of the bridging sheet formation of HIV-1 glycoprotein gp120.
    Da LT; Quan JM; Wu YD
    J Phys Chem B; 2009 Oct; 113(43):14536-43. PubMed ID: 19813706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors.
    Teixeira C; Serradji N; Maurel F; Barbault F
    Eur J Med Chem; 2009 Sep; 44(9):3524-32. PubMed ID: 19410340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: an emerging opportunity for drug development.
    Kadow J; Wang HG; Lin PF
    Curr Opin Investig Drugs; 2006 Aug; 7(8):721-6. PubMed ID: 16955683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for the disulfide-bonded region of human immunodeficiency virus type 1 gp41 in receptor-triggered activation of membrane fusion function.
    Bellamy-McIntyre AK; Bär S; Ludlow L; Drummer HE; Poumbourios P
    Biochem Biophys Res Commun; 2010 Apr; 394(4):904-8. PubMed ID: 20230797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events.
    Ho HT; Fan L; Nowicka-Sans B; McAuliffe B; Li CB; Yamanaka G; Zhou N; Fang H; Dicker I; Dalterio R; Gong YF; Wang T; Yin Z; Ueda Y; Matiskella J; Kadow J; Clapham P; Robinson J; Colonno R; Lin PF
    J Virol; 2006 Apr; 80(8):4017-25. PubMed ID: 16571818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.
    Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K
    Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 activation of HIV fusion.
    Sattentau QJ
    Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action.
    Langley DR; Kimura SR; Sivaprakasam P; Zhou N; Dicker I; McAuliffe B; Wang T; Kadow JF; Meanwell NA; Krystal M
    Proteins; 2015 Feb; 83(2):331-50. PubMed ID: 25401969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of small molecular inhibitors targeting HIV-1 gp120-CD4 interaction drived from BMS-378806.
    Liu T; Huang B; Zhan P; De Clercq E; Liu X
    Eur J Med Chem; 2014 Oct; 86():481-90. PubMed ID: 25203778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Acting BMS-378806 Analogues Stabilize the State-1 Conformation of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins.
    Zou S; Zhang S; Gaffney A; Ding H; Lu M; Grover JR; Farrell M; Nguyen HT; Zhao C; Anang S; Zhao M; Mohammadi M; Blanchard SC; Abrams C; Madani N; Mothes W; Kappes JC; Smith AB; Sodroski J
    J Virol; 2020 May; 94(10):. PubMed ID: 32161177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins.
    Si Z; Madani N; Cox JM; Chruma JJ; Klein JC; Schön A; Phan N; Wang L; Biorn AC; Cocklin S; Chaiken I; Freire E; Smith AB; Sodroski JG
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):5036-41. PubMed ID: 15051887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomic insight into the CD4 binding-induced conformational changes in HIV-1 gp120.
    Hsu ST; Bonvin AM
    Proteins; 2004 May; 55(3):582-93. PubMed ID: 15103622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.
    Curreli F; Haque K; Xie L; Qiu Q; Xu J; Yong W; Tong X; Debnath AK
    Bioorg Med Chem; 2015 Dec; 23(24):7618-28. PubMed ID: 26602829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of a nonproductive conformational change in gp120 by a small molecule HIV type 1 entry inhibitor.
    Huang L; Lai W; Ho P; Chen CH
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):28-32. PubMed ID: 17263629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized changes in the gp120 envelope glycoprotein confer resistance to human immunodeficiency virus entry inhibitors BMS-806 and #155.
    Madani N; Perdigoto AL; Srinivasan K; Cox JM; Chruma JJ; LaLonde J; Head M; Smith AB; Sodroski JG
    J Virol; 2004 Apr; 78(7):3742-52. PubMed ID: 15016894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
    Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
    Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
    Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
    Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the conformational flexibility of piperazine derivatives important to inhibit HIV-1 replication?
    Teixeira C; Serradji N; Amroune S; Storck K; Rogez-Kreuz C; Clayette P; Barbault F; Maurel F
    J Mol Graph Model; 2013 Jul; 44():91-103. PubMed ID: 23748247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.